Advertisement
CNC vs CVS
Which Stock Would AI Choose? Centene Corporation (CNC) vs. CVS Health Corporation (CVS) Stock Comparison
Key Takeaways
- Centene Corporation (CNC) focuses primarily on government-sponsored managed care programs such as Medicaid, while CVS Health Corporation (CVS) operates a diversified model spanning retail pharmacy, pharmacy benefit management (PBM), and health insurance through Aetna.
- Recent market activity shows CNC delivering a strong second-quarter 2026 earnings beat with raised full-year guidance, contrasting with CVS benefiting from earlier first-quarter results and ongoing analyst price target increases.
- Both stocks have posted solid year-to-date gains in a healthcare sector influenced by cost management and policy developments, though relative momentum has varied with earnings cycles.
- Risk factors differ: CNC faces membership fluctuations in Medicaid, while CVS navigates reimbursement pressures and legal matters in its integrated operations.
- Sector exposure for both centers on U.S. healthcare, with CNC more concentrated in government programs and CVS offering broader consumer-facing and specialty services.
- Market sentiment reflects cautious optimism for both, supported by operational efficiencies and guidance updates amid broader economic conditions.
Introduction
Centene Corporation (CNC) and CVS Health Corporation (CVS) represent two distinct approaches within the U.S. healthcare sector, making their stock comparison relevant for investors and traders seeking exposure to managed care, pharmacy services, and integrated health solutions. This analysis examines recent performance, business models, and market positioning to highlight contrasts that may inform portfolio decisions. Professional and retail investors monitoring healthcare trends, earnings cycles, and relative valuation often review such pairs for diversification or tactical allocation purposes in the current environment.
CNC Overview and Recent Performance
Centene Corporation (CNC) is a leading managed care organization specializing in government-sponsored health programs, primarily Medicaid, along with Medicare and marketplace offerings. The company emphasizes locally branded plans and operational efficiencies across its segments. In recent weeks, CNC reported second-quarter 2026 results that exceeded expectations, with revenue growth of approximately 9.9% year-over-year and adjusted earnings per share significantly above consensus. The firm raised its full-year outlook, citing improved margins and cost containment in Medicaid and other lines. These developments contributed to positive sentiment and stock appreciation following the release, reflecting investor focus on execution in core government programs amid fluctuating membership trends.
CVS Overview and Recent Performance
CVS Health Corporation (CVS) operates as an integrated health solutions provider with retail pharmacies, pharmacy benefit management through Caremark, and insurance via Aetna. This diversified structure serves consumers through multiple channels. Recent market activity has featured continued analyst support, including upward revisions to price targets, building on earlier first-quarter 2026 results that prompted raised full-year guidance. The stock has consolidated gains in a constructive range, supported by initiatives in specialty areas such as weight-loss medications. Broader performance reflects steady institutional interest amid sector dynamics, with emphasis on margin stability and cash flow generation in its multifaceted operations.
Trending AI Robots
Tickeron’s Trending AI Robots page curates the most suitable AI trading bots from a library of hundreds that trade thousands of different tickers. Only those demonstrating strong alignment with prevailing market conditions earn placement in this section. Available bots span a wide range of trading styles, strategies, timeframes, and performance statistics, including varying win rates, profit factors, and drawdown profiles tailored to specific assets. This diversity allows users to explore options suited to different risk tolerances and market views. For more details on these tools and their current trending selections, visit Trending AI Robots.
Head-to-Head Comparison
Centene Corporation (CNC) and CVS Health Corporation (CVS) differ markedly in business models: CNC concentrates on Medicaid-centric managed care with localized operations, whereas CVS leverages vertical integration across retail, PBM, and insurance for broader revenue streams. Growth drivers for CNC center on government program participation and medical cost management, while CVS benefits from pharmacy volume, specialty services, and insurance synergies. Recent momentum has favored CNC following its latest earnings beat and outlook raise, compared with CVS sustaining gains from prior updates and analyst upgrades. Risk factors include policy exposure for both, though CNC contends more directly with Medicaid enrollment shifts and CVS with reimbursement and regulatory matters. Market sentiment remains balanced, with sector positioning highlighting trade-offs between specialized government focus and diversified consumer-health integration.
Tickeron AI Verdict
Based on observable factors such as recent trend consistency following earnings releases, stability in guidance updates, and relative positioning within healthcare, Tickeron’s AI models indicate a probabilistic preference for Centene Corporation (CNC) in the near term. This assessment reflects stronger alignment with current catalysts in government-sponsored segments, though outcomes remain subject to ongoing market conditions and sector developments. Investors should evaluate these insights alongside individual research.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNC is a StrongBuy and CVS is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNC’s FA Score shows that 0 FA rating(s) are green whileCVS’s FA Score has 2 green FA rating(s).
- CNC’s FA Score: 0 green, 5 red.
- CVS’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNC’s TA Score shows that 6 TA indicator(s) are bullish while CVS’s TA Score has 5 bullish TA indicator(s).
- CNC’s TA Score: 6 bullish, 2 bearish.
- CVS’s TA Score: 5 bullish, 5 bearish.
Price Growth
CNC (@Managed Health Care) experienced а +2.58% price change this week, while CVS (@Managed Health Care) price change was +1.53% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +1.66%. For the same industry, the average monthly price growth was -6.66%, and the average quarterly price growth was +53.03%.
Reported Earning Dates
CNC is expected to report earnings on Oct 27, 2026.
CVS is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Managed Health Care (+1.66% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| CNC | CVS | CNC / CVS | |
| Capitalization | 33.3B | 124B | 27% |
| EBITDA | -2.73B | 11.1B | -25% |
| Gain YTD | 63.961 | 25.291 | 253% |
| P/E Ratio | 9.06 | 25.64 | 35% |
| Revenue | 203B | 408B | 50% |
| Total Cash | 27.1B | N/A | - |
| Total Debt | 16.1B | 78.3B | 21% |
CNC | CVS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 12 | 61 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | 2 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 69 | |
SMR RATING 1..100 | 97 | 87 | |
PRICE GROWTH RATING 1..100 | 38 | 49 | |
P/E GROWTH RATING 1..100 | 68 | 21 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVS's Valuation (2) in the Drugstore Chains industry is somewhat better than the same rating for CNC (64) in the Managed Health Care industry. This means that CVS’s stock grew somewhat faster than CNC’s over the last 12 months.
CVS's Profit vs Risk Rating (69) in the Drugstore Chains industry is in the same range as CNC (100) in the Managed Health Care industry. This means that CVS’s stock grew similarly to CNC’s over the last 12 months.
CVS's SMR Rating (87) in the Drugstore Chains industry is in the same range as CNC (97) in the Managed Health Care industry. This means that CVS’s stock grew similarly to CNC’s over the last 12 months.
CNC's Price Growth Rating (38) in the Managed Health Care industry is in the same range as CVS (49) in the Drugstore Chains industry. This means that CNC’s stock grew similarly to CVS’s over the last 12 months.
CVS's P/E Growth Rating (21) in the Drugstore Chains industry is somewhat better than the same rating for CNC (68) in the Managed Health Care industry. This means that CVS’s stock grew somewhat faster than CNC’s over the last 12 months.
| CNC | CVS | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 66% |
| Stochastic ODDS (%) | 1 day ago 58% | 1 day ago 62% |
| Momentum ODDS (%) | 1 day ago 66% | 1 day ago 56% |
| MACD ODDS (%) | 1 day ago 60% | 1 day ago 55% |
| TrendWeek ODDS (%) | 1 day ago 64% | 1 day ago 64% |
| TrendMonth ODDS (%) | 1 day ago 65% | 1 day ago 55% |
| Advances ODDS (%) | 11 days ago 62% | 1 day ago 68% |
| Declines ODDS (%) | 17 days ago 63% | 5 days ago 58% |
| BollingerBands ODDS (%) | N/A | 1 day ago 69% |
| Aroon ODDS (%) | 1 day ago 66% | 1 day ago 73% |
Advertisement
CNC and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNC has been closely correlated with MOH. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if CNC jumps, then MOH could also see price increases.
CVS and
Correlation & Price change
A.I.dvisor indicates that over the last year, CVS has been loosely correlated with UNH. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CVS jumps, then UNH could also see price increases.